ALLMedicine™ Aicardi Syndrome Center
Research & Reviews 45 results
Journal of Child Neurology; Sanchez MAR, Cervenka MC et. al.
Jul 10th, 2021 - Aicardi syndrome is a rare neurodevelopmental disorder associated with epilepsy in females. Ketogenic diet therapy represents a possible nonpharmacologic treatment in Aicardi syndrome patients. All patients with Aicardi syndrome seen at Johns Hopk...
Nov 12th, 2020 - Aicardi syndrome is a neurodevelopmental disorder that affects primarily females. Initially it was characterized by a typical triad of agenesis of the corpus callosum, central chorioretinal lacunae, and infantile spasms. As more affected individua...
BMJ Case Reports; Aggarwal D, Majhi D et. al.
Aug 28th, 2020 - Many of the ophthalmic pathologies can co-exist and when taken together can at times give a clue to a life-threatening systemic condition. Presented here is a case of Aicardi syndrome in a prematurely born baby with retinopathy of prematurity . Ea...
American Journal of Medical Genetics. Part A; Masnada S, Gibelli D et. al.
Aug 17th, 2020 - Aicardi syndrome (AIC) is a rare congenital neurodevelopmental disorder of unknown etiology, that affects almost exclusively females, originally characterized by corpus callosum agenesis, chorioretinal lacunae, and infantile spasms. The current di...
European Journal of Ophthalmology; Al-Moujahed A, Callaway NF et. al.
Jul 18th, 2020 - Aicardi syndrome is an X-linked condition that is associated with multiple ophthalmic malformations. Here, we report the first published fluorescein angiography (FA) study of a morning glory optic nerve in a patient with Aicardi syndrome and contr...
Clinicaltrials.gov 1 results
Aug 10th, 2018 - Aicardi syndrome is a sporadic X-linked dominant, presumably male-lethal, neurodevelopmental disorder. It was initially characterized by agenesis of the corpus callosum, neuronal migration defects, eye abnormalities (chorioretinal lacunae, colobom...
News 1 results
M. Alexander Otto
Dec 10th, 2019 - BALTIMORE – Sodium channel blocker antiepileptic drugs increase the risk of infantile spasms sevenfold in children with Down syndrome, tuberous sclerosis complex, hypoxic-ischemic encephalopathy, and other nonsyndromic epilepsy conditions with inf.